1. Home
  2. DTCK vs NVNO Comparison

DTCK vs NVNO Comparison

Compare DTCK & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Davis Commodities Limited

DTCK

Davis Commodities Limited

HOLD

Current Price

$0.29

Market Cap

7.7M

Sector

Industrials

ML Signal

HOLD

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

HOLD

Current Price

$11.69

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTCK
NVNO
Founded
1999
1987
Country
Singapore
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
7.3M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
DTCK
NVNO
Price
$0.29
$11.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.0M
23.0K
Earning Date
12-23-2025
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$160,529,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.43
N/A
52 Week Low
$0.23
$9.81
52 Week High
$6.89
$196.70

Technical Indicators

Market Signals
Indicator
DTCK
NVNO
Relative Strength Index (RSI) 41.71 93.18
Support Level $0.30 $9.81
Resistance Level $0.33 $12.79
Average True Range (ATR) 0.03 0.51
MACD 0.02 1.36
Stochastic Oscillator 3.33 92.91

Price Performance

Historical Comparison
DTCK
NVNO

About DTCK Davis Commodities Limited

Davis Commodities Ltd is an agricultural commodity trading company based in Singapore, which specializes in the trading of three main categories of agricultural commodities, namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa, and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage, and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil, and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: